A. Hoos, Development of immuno-oncology drugs ??? from CTLA4 to PD1 to the next generations, Nature Reviews Drug Discovery, vol.33, issue.4, pp.235-247, 2016.
DOI : 10.1158/1078-0432.CCR-09-2376

N. Labarriere, A. Khammari, F. Lang, and B. Dreno, Is antigen specificity the key to efficient adoptive T-cell therapy?, Immunotherapy, vol.3, issue.4, pp.495-505, 2011.
DOI : 10.2217/imt.11.16

J. Kung, D. Colognori, and J. Lee, Long Noncoding RNAs: Past, Present, and Future, Genetics, vol.193, issue.3, pp.651-669, 2013.
DOI : 10.1534/genetics.112.146704

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583990

M. Bobinet, V. Vignard, L. Florenceau, F. Lang, N. Labarriere et al., Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation, PLoS ONE, vol.130, issue.9, p.75421, 2013.
DOI : 10.1371/journal.pone.0075421.g005

B. Chalopin, L. Florenceau, D. Fradin, N. Labarriere, and A. Moreau-aubry, A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigens, Melanoma Research, vol.25, issue.4, pp.279-283, 2015.
DOI : 10.1097/CMR.0000000000000167

URL : https://hal.archives-ouvertes.fr/inserm-01280880

N. Ingolia, L. Lareau, and J. Weissman, Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes, Cell, vol.147, issue.4, pp.789-802, 2011.
DOI : 10.1016/j.cell.2011.10.002

J. Smith, J. Alvarez-dominguez, N. Kline, N. Huynh, S. Geisler et al., Translation of Small Open Reading Frames within Unannotated RNA Transcripts in Saccharomyces cerevisiae, Cell Reports, vol.7, issue.6, pp.1858-1866, 2014.
DOI : 10.1016/j.celrep.2014.05.023

D. Carbonnelle, V. Vignard, D. Sehedic, A. Moreau-aubry, L. Florenceau et al., The Melanoma Antigens MELOE-1 and MELOE

Y. Godet, J. Desfrancois, V. Vignard, D. Schadendorf, A. Khammari et al., Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy, European Journal of Immunology, vol.42, issue.6, pp.1786-1794, 2010.
DOI : 10.1002/eji.200940132

M. Bobinet, V. Vignard, A. Rogel, A. Khammari, B. Dreno et al., MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients, PLoS ONE, vol.60, issue.12, p.51716, 2012.
DOI : 10.1371/journal.pone.0051716.t001

A. Rogel, V. Vignard, M. Bobinet, N. Labarriere, and F. Lang, P018. A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope, Melanoma Research, vol.21, pp.327-337, 2011.
DOI : 10.1097/01.cmr.0000399479.31979.e8

M. Petz, D. Kozina, H. Huber, T. Siwiec, J. Seipelt et al., The leader region of Laminin B1 mRNA confers cap-independent translation, Nucleic Acids Research, vol.35, issue.8, pp.2473-2482, 2007.
DOI : 10.1093/nar/gkm096

E. Martinuzzi, G. Afonso, M. Gagnerault, G. Naselli, D. Mittag et al., acDCs enhance human antigen-specific T-cell responses, Blood, vol.118, issue.8, pp.2128-2137, 2011.
DOI : 10.1182/blood-2010-12-326231

M. Croyal, K. Ouguerram, M. Passard, V. Ferchaud-roucher, M. Chetiveaux et al., Effects of Extended-Release Nicotinic Acid on Apolipoprotein (a) Kinetics in Hypertriglyceridemic PatientsSignificance, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.35, issue.9, pp.2042-2047, 2015.
DOI : 10.1161/ATVBAHA.115.305835

J. Prensner and A. Chinnaiyan, The Emergence of lncRNAs in Cancer Biology, Cancer Discovery, vol.1, issue.5, pp.391-407, 2011.
DOI : 10.1158/2159-8290.CD-11-0209

Y. Godet, A. Moreau-aubry, D. Mompelat, V. Vignard, A. Khammari et al., An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context. Cancer immunol immunother, pp.431-439, 2010.

A. Bisio, E. Latorre, V. Andreotti, B. Bressac-de-paillerets, H. M. Scarra et al., The 5?-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding, Oncotarget, vol.6, pp.39980-39994, 2015.

T. Dobson, J. Chen, and L. Krushel, Dysregulating IRES-Dependent Translation Contributes to Overexpression of Oncogenic Aurora A Kinase, Molecular Cancer Research, vol.11, issue.8, pp.887-900, 2013.
DOI : 10.1158/1541-7786.MCR-12-0707

M. Faye and M. Holcik, The role of IRES trans-acting factors in carcinogenesis, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1849, issue.7, pp.887-897, 2015.
DOI : 10.1016/j.bbagrm.2014.09.012

M. Petz, N. Them, H. Huber, H. Beug, and W. Mikulits, La enhances IRES-mediated translation of laminin B1 during malignant epithelial to mesenchymal transition, Nucleic Acids Research, vol.40, issue.1, pp.290-302, 2012.
DOI : 10.1093/nar/gkr717

Z. Xiong, E. Liu, Y. Yan, R. Silver, F. Yang et al., An Unconventional Antigen Translated by a Novel Internal Ribosome Entry Site Elicits Antitumor Humoral Immune Reactions, The Journal of Immunology, vol.177, issue.7, pp.4907-4916, 2006.
DOI : 10.4049/jimmunol.177.7.4907

S. Weingarten-gabbay, S. Elias-kirma, R. Nir, A. Gritsenko, N. Stern-ginossar et al., Comparative genetics. Systematic discovery of capindependent translation sequences in human and viral genomes, Science, vol.351, 2016.